Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 792.70
-12.20 (-1.52%)
Feb 16, 2026, 1:12 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 16.87 billion as of February 13, 2026. Its market cap has decreased by -11.18% in one year.
Market Cap
16.87B
Enterprise Value
14.58B
Revenue
8.68B
Ranking
n/a
PE Ratio
25.60
Stock Price
792.70
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 16.87B, an increase of 90.12%. That is a compound annual growth rate of 15.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 16.87B | 1.24% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 42.87B |
| Innova Captab | 38.85B |
| Orchid Pharma | 33.70B |
| RPG Life Sciences | 32.66B |
| Solara Active Pharma Sciences | 24.07B |
| Indoco Remedies | 18.68B |
| Beta Drugs | 13.87B |
| Jagsonpal Pharmaceuticals | 11.68B |